These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1206 related items for PubMed ID: 30695734

  • 1. Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs.
    Sankrityayan H, Kulkarni YA, Gaikwad AB.
    Pharmacol Res; 2019 Mar; 141():574-585. PubMed ID: 30695734
    [Abstract] [Full Text] [Related]

  • 2. Interplay between the miRNome and the epigenetic machinery: Implications in health and disease.
    Poddar S, Kesharwani D, Datta M.
    J Cell Physiol; 2017 Nov; 232(11):2938-2945. PubMed ID: 28112397
    [Abstract] [Full Text] [Related]

  • 3. Epigenetic Regulations in Diabetic Nephropathy.
    Lu Z, Liu N, Wang F.
    J Diabetes Res; 2017 Nov; 2017():7805058. PubMed ID: 28401169
    [Abstract] [Full Text] [Related]

  • 4. Interplay between microRNAs and the epigenetic machinery: an intricate network.
    Iorio MV, Piovan C, Croce CM.
    Biochim Biophys Acta; 2010 Nov; 1799(10-12):694-701. PubMed ID: 20493980
    [Abstract] [Full Text] [Related]

  • 5. Targeting epigenetic regulators for treating diabetic nephropathy.
    Kushwaha K, Garg SS, Gupta J.
    Biochimie; 2022 Nov; 202():146-158. PubMed ID: 35985560
    [Abstract] [Full Text] [Related]

  • 6. The roles of microRNAs in epigenetic regulation.
    Yao Q, Chen Y, Zhou X.
    Curr Opin Chem Biol; 2019 Aug; 51():11-17. PubMed ID: 30825741
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.
    Zanchi C, Macconi D, Trionfini P, Tomasoni S, Rottoli D, Locatelli M, Rudnicki M, Vandesompele J, Mestdagh P, Remuzzi G, Benigni A, Zoja C.
    Diabetologia; 2017 Jun; 60(6):1114-1125. PubMed ID: 28364255
    [Abstract] [Full Text] [Related]

  • 8. Epigenetics and microRNAs.
    Chuang JC, Jones PA.
    Pediatr Res; 2007 May; 61(5 Pt 2):24R-29R. PubMed ID: 17413852
    [Abstract] [Full Text] [Related]

  • 9. MicroRNAs and epigenetics.
    Sato F, Tsuchiya S, Meltzer SJ, Shimizu K.
    FEBS J; 2011 May; 278(10):1598-609. PubMed ID: 21395977
    [Abstract] [Full Text] [Related]

  • 10. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective.
    Zheng W, Guo J, Liu ZS.
    Clin Epigenetics; 2021 Apr 21; 13(1):87. PubMed ID: 33883002
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA: A new generation therapeutic target in diabetic nephropathy.
    Dewanjee S, Bhattacharjee N.
    Biochem Pharmacol; 2018 Sep 21; 155():32-47. PubMed ID: 29940170
    [Abstract] [Full Text] [Related]

  • 12. Long non-coding RNAs as emerging regulators of miRNAs and epigenetics in diabetes-related chronic kidney disease.
    Shelke V, Kale A, Sankrityayan H, Anders HJ, Gaikwad AB.
    Arch Physiol Biochem; 2024 Apr 21; 130(2):230-241. PubMed ID: 34986074
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA epigenetic signatures in human disease.
    Piletič K, Kunej T.
    Arch Toxicol; 2016 Oct 21; 90(10):2405-19. PubMed ID: 27557899
    [Abstract] [Full Text] [Related]

  • 14. Epigenetics and miRNAs in human cancer.
    Fabbri M, Calin GA.
    Adv Genet; 2010 Oct 21; 70():87-99. PubMed ID: 20920746
    [Abstract] [Full Text] [Related]

  • 15. Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy.
    Yuan H, Reddy MA, Deshpande S, Jia Y, Park JT, Lanting LL, Jin W, Kato M, Xu ZG, Das S, Natarajan R.
    Antioxid Redox Signal; 2016 Mar 01; 24(7):361-75. PubMed ID: 26492974
    [Abstract] [Full Text] [Related]

  • 16. An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs.
    Huang D, Cui L, Ahmed S, Zainab F, Wu Q, Wang X, Yuan Z.
    Food Chem Toxicol; 2019 Jan 01; 123():574-594. PubMed ID: 30408543
    [Abstract] [Full Text] [Related]

  • 17. The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression.
    Mafi A, Aghadavod E, Mirhosseini N, Mobini M, Asemi Z.
    J Cell Physiol; 2018 Jan 01; 234(1):42-50. PubMed ID: 30078212
    [Abstract] [Full Text] [Related]

  • 18. Epigenetic modifications in the pathogenesis of diabetic nephropathy.
    Reddy MA, Tak Park J, Natarajan R.
    Semin Nephrol; 2013 Jul 01; 33(4):341-53. PubMed ID: 24011576
    [Abstract] [Full Text] [Related]

  • 19. MicroRNAs and Epigenetics.
    Moutinho C, Esteller M.
    Adv Cancer Res; 2017 Jul 01; 135():189-220. PubMed ID: 28882223
    [Abstract] [Full Text] [Related]

  • 20. Regulation of microRNAs by epigenetics and their interplay involved in cancer.
    Liu X, Chen X, Yu X, Tao Y, Bode AM, Dong Z, Cao Y.
    J Exp Clin Cancer Res; 2013 Nov 22; 32(1):96. PubMed ID: 24261995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.